Andrew Hore – Quoted Micro 17 May 2021
AQUIS STOCK EXCHANGE United Win Asia has invested £3.15m in Samarkand (SMK) at 115p a share, which is the same as the original placing price but well below the market price. United Win Asia is part of a logistics group and this fits well with Samarkand’s ecommerce platform. Clarify Pharma plans to raise £5m at […]
Andrew Hore – Quoted Micro 29 March 2021
AQUIS STOCK EXCHANGE New Apex segment entry Samarkand (SMK) has got off to a strong start. At one point, shares were changing hands at 142p, against the placing price of 115p, but they ended the week at 123.5p (120p/127p). There was £15.4m raised after expenses. The company has developed e-commerce software technology known as Nomad. […]
Andrew Hore – Quoted Micro 25 January 2021
AQUIS STOCK EXCHANGE Rutherford Health (RUTH) has signed contracts with the NHS that underpin a significant proportion of its fixed costs. More cash will be required in order to take advantage of the potential for the cancer care clinics. The cash will be needed in the next few months and could be raised at the […]
Andrew Hore – Quoted Micro 23 November 2020
AQUIS STOCK EXCHANGE Daniel Thwaites (THW) had a strong eleven months in the year to March 2020, but the final month was unsurprisingly poor for the brewer and pubs operator. Full year revenues edged up from £96.9m to £98.1m, while pre-tax profit fell from £4.5m to £3.6m. Net debt was reduced from £69.7m to £65.4m, […]
Andrew Hore – Quoted Micro 26 October 2020
AQUIS STOCK EXCHANGE Truspine Technologies (TSP) says that the latest tests of Cervi-Lok, which is a spinal stabilisation device, have been positive. The tests used a computer-generated model and it showed that Cervi-Lok had a reduction in range of motion that was better than existing screw-based fixation systems. FDA clearance is expected early next year. […]
Andrew Hore – Quoted Micro 14 September 2020
AQUIS STOCK EXCHANGE Investment company S-Ventures is set to join the market on 16 September. The strategy is to make investments in consumer health and organic food businesses in the UK and Europe. The S-Ventures management will use their expertise to help smaller brands grow faster and achieve greater scale. Up to three acquisitions are […]
Andrew Hore – Quoted Micro 24 August 2020
AQUIS STOCK EXCHANGE Medical device developer TruSpine Technologies (TSP) ended the week at 34.5p (32p/37p). TruSpine has raised £1.4m at 36p a share with a commitment for a further £250,000. This should provide enough cash until Cervi-Lok, which is one of the three spinal stabilisation devices being developed, starts to generate sales. Coinsilium Group Ltd […]
Andrew Hore – Quoted Micro 20 July 2020
AQUIS STOCK EXCHANGE In the year to February 2020, Rutherford Health (RUTH) nearly quadrupled its revenues from £1.47m to £5.61m, although the loss increased from £21.5m to £29.3m. There were three proton beam cancer treatment centres open at the end of the period, but two were not operating for long. They have continued to operate […]
Andrew Hore – Quoted Micro 8 June 2020
AQUIS STOCK EXCHANGE Sativa Group (SATI) has agreed a merger with Stillcana Inc. The share swap is 0.33507 of a Stillcanna share for every Sativa share. That values the cannabis products company at £10.7m and its shareholders will own 65% of the enlarged group. Trading in Sativa shares restarted on 4 June. Engineering businesses consolidator […]
Andrew Hore – Quoted Micro 27 April 2020
AQUIS STOCK EXCHANGE Cannabis products-focused company Sativa (SATI) has received a bid approach from StillCana Inc, which has built two high volume CBD extraction facilities in Europe. StillCana is Europe’s largest producer of CBD distillate and isolate. StillCana plans to offer 0.33651 of one share for each Sativa share. Sativa shareholders would own 65% of […]